Skip to main content

Pharmacology Tips for Commonly Used AEDS

  • Chapter
  • First Online:
The Acute Neurology Survival Guide
  • 1832 Accesses

Abstract

Pharmacology pearls including dosing, monitoring, considerations for levetiracetam, valproate, phenytoin, and lacosamide. Addresses dosing issues with phenytoin, behavioral side effect management of levetiracetam and hyperammonemia with valproate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Marion S, et al. Pyridoxine add-on treatment for the control of behavioral adverse effects induced by levetiracetam in children: a case-control prospective study. Ann Pharmacother. 2018;52(7):645–9.

    Article  Google Scholar 

  2. Major P, et al. Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results. Epilepsy Behav. 2008;13(3):557–9.

    Article  Google Scholar 

  3. Mahmoud A, Tabassum S, Al Enazi S, Lubbad N, Al Wadei A, Al Otaibi A, Jad L, Benini R. Amelioration of Levetiracetam-Induced Behavioral Side Effects by Pyridoxine. A Randomized Double Blind Controlled Study. Pediatr Neurol. 2021;119:15–21. PMID: 33823377.

    Google Scholar 

  4. Major P, Greenberg E, Khan A, Thiele EA. Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results. Epilepsy Behav. 2008;13(3):557–9. PMID: 18647662.

    Google Scholar 

  5. Mock CM, Schwetschenau KH. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm. 2012;69(1):35–9. PMID: 22180549.

    Google Scholar 

  6. Glatstein M, Bonifacio Rino P, de Pinho S, Scolnik D, Pivko-Levi D, Hoyte C. Levocarnitine for the Treatment of Valproic Acid-Induced Hyperammonemic Encephalopathy in Children: The Experience of a Large, Tertiary Care Pediatric Hospital and a Poison Center. PMID: 29232283.

    Google Scholar 

  7. Barra ME, Phillips KM, Chung DY, et al. A novel correction equation avoids high-magnitude errors in interpreting therapeutic drug monitoring of phenytoin among critically ill patients. Ther Drug Monit 2020;42(4):617–25.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Megan E. Barra .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Barra, M.E. (2022). Pharmacology Tips for Commonly Used AEDS. In: Albin, C.S., Zafar, S.F. (eds) The Acute Neurology Survival Guide. Springer, Cham. https://doi.org/10.1007/978-3-030-75732-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-75732-8_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-75731-1

  • Online ISBN: 978-3-030-75732-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics